Physician profile
James C Melville
NPI 1972751907
$239,281.38
in general payments reported to CMS, 2019-2025
21 companies · $74K in 2025
The $74K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $24K · 2021: $6,625 · 2022: $15K · 2023: $31K · 2024: $59K · 2025: $74K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $84K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Food and Beverage: $14K · Travel and Lodging: $13K · Education: $7,500 · Consulting Fee: $6,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $83,550.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,056.25 |
| Food and Beverage | $14,318.88 |
| Travel and Lodging | $13,031.70 |
| Education | $7,500.00 |
| Consulting Fee | $6,111.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $142,356.69 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Kerecis Limited | $82,003.41 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Kls-Martin L.P. | $7,217.02 | 2019-2025 | |
| Medical Device Business Services, INC. | $3,030.00 | 2020 | |
| Acell, INC. | $2,175.01 | 2020 | |
| Checkpoint Surgical, INC | $440.31 | 2019-2025 | Checkpoint Stimulators |
| Depuy Synthes Sales INC. | $328.48 | 2019-2023 | Matrixmandible |
| Integra Lifesciences Corporation | $304.68 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $300.94 | 2019-2021 | |
| Becton, Dickinson and Company | $261.25 | 2024 | |
| Biotissue Holdings INC. | $223.47 | 2022 | |
| Stryker Corporation | $217.81 | 2021-2022 | |
| Baxter Healthcare | $122.40 | 2025 | Perclot |
| Lifenet Health | $105.36 | 2019 | |
| Acera Surgical, INC. | $69.72 | 2024 | Restrata Wound Matrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $39.60 | 2025 | Matriderm |
| Tempus Ai, INC | $24.20 | 2025 | Xt Cdx |
| Davol INC. | $24.15 | 2024 | Arista Ah Flexitip |
| 3d Systems | $22.83 | 2021 | |
| Ethicon US, LLC | $14.05 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Melville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.